Lantheus Holdings (LNTH) Stock Price, Quote, News & History | Benzinga

Lantheus Holdings Inc (LNTH) Stock Price, Quote, News & History

LNTHNASDAQ

Trade with Public

Trade with Public

$99.97

-0.27-0.27%

At close: Aug 20, 5:00 PM EST

$99.97

-0.27-0.27%

Pre-Market: 4:05 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$99.97

Volume / Avg.

250.00 / 1.35M

Day Range

- - -

52 Wk Range

49.67 - 111.86

Market Cap

$6.53B

P/E Ratio

23.92

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

12.85%

Days to Cover

6.56

Recent Lantheus Holdings, Inc. News

FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics

Lantheus receives FDA approval for PET imaging agent used to evaluate adults for Alzheimer's disease by identifying tau pathology.

Vandana Singh

Analyst Calls Curium's $8 Billion Lantheus Buyout An 'Excellent Outcome' For Shareholders

CapVest-backed Curium agrees to acquire Lantheus for up to $8B, expanding its global footprint in nuclear medicine.

Vandana Singh

Under the Radar: 3 Boring Small Caps That Could Return 10x

Investors spend an enormous amount of time searching for the next stock that can rise 10 times in value. They study disruptive technologies, enormous addressable markets, charismatic founders, and whatever investment

Tim Melvin

FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit

Lantheus receives FDA Complete Response Letter for LNTH-2501. William Blair pushes Octevy sales outlook back by one year.

Vandana Singh

Concentrix, AeroVironment And 3 Stocks To Watch Heading Into Monday

U.S. stock futures up, watch Concentrix Corp, Lantheus Holdings, AeroVironment, Viridian Therapeutics, Universe Pharmaceuticals for earnings and news.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

412.80M

Investing Cash Flow (TTM)

-307.02M

Financing Cash Flow (TTM)

-207.07M

Free Cash Flow (TTM)

387.83M

Capital Expenditure (TTM)

-24.97M

Net Change in Cash (TTM)

-101.28M

Analyst Trends and Forecast

2

Apr

3

May

0

0

0

0

Jun

4

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.56B

PE Ratio (TTM)

23.92

PE Ratio (FWD)

17.64

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.25

PB Ratio (TTM)

4.97

Earnings Yield % (TTM)

4.18%

Earnings Yield % (FWD)

5.67%

EV / EBITDA (TTM)

13.91

Price / EBITDA (TTM)

14.04

Price / Free Cash Flow (TTM)

17.06

Book Value / Share

$20.10

Company Debt

Total Debt

$571.05M

LT Debt

$570.35M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.11M

Total Cash

$593.30M

Debt to Equity

0.48

Issuance of Debt (TTM)

-$1.11M

Repayment of Debt (TTM)

-$1.11M

Key Statistics

Open

-

Close

$99.97

Volume / Avg.

250.00 / 1.35M

Day Range

- - -

52 Wk Range

49.67 - 111.86

Market Cap

$6.53B

P/E Ratio

23.92

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

12.85%

Days to Cover

6.56

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostic...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Lantheus Holdings (LNTH) stock?

A

You can purchase shares of Lantheus Holdings (NASDAQ:LNTH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Lantheus Holdings (LNTH) competitors?

A

Other companies in Lantheus Holdings’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).

Q

What is the forecast, or price target, for Lantheus Holdings (LNTH) stock?

A

Lantheus Holdings has a consensus price target of $110.55.

Q

What is the current price for Lantheus Holdings (LNTH)?

A

The stock price for Lantheus Holdings (NASDAQ: LNTH) is $99.97 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Lantheus Holdings (LNTH) pay a dividend?

A

There are no upcoming dividends for Lantheus Holdings.

Q

When is Lantheus Holdings (NASDAQ:LNTH) reporting earnings?

A

Lantheus Holdings does not have any upcoming earnings scheduled.

Q

Is Lantheus Holdings (LNTH) going to split?

A

There is no upcoming split for Lantheus Holdings.

Q

What sector and industry does Lantheus Holdings (LNTH) operate in?

A

Lantheus Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.